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1. Introduction 
 
This document, supported by both the International Society for Clinical 
Hemorheology and the European Society for Clinical Hemorheology and 
Microcirculation, proposes new guidelines for hemorheological methods used in 
experimental and clinical studies. It is based on a similar document entitled: 
“Guidelines for measurement of blood viscosity and erythrocyte deformability” 
published in 1986 by the Expert Panel on Blood Rheology of the International 
Committee for Standardization in Hematology [46]. Recent methods, techniques 
and instruments, as well as new approaches to interpretation of results, are added to 
these new guidelines; wide spread adoption should improve comparability between 
hemorheological laboratories and increase the reliability of rheological tests. 
 
 
2. Collection of blood samples  
 
2.1. Sampling time and conditions  
 
Hemorheological parameters may be affected by the following factors: diurnal 
variation, level of hydration, recent fluid/food intake, physical activity, drugs and 
environmental conditions (e.g., temperature, humidity) [3, 16, 60, 65, 77, 81]. These 
factors should be considered and standardized prior to and during sampling. Since 
the “wash out” phase of certain drugs may take several weeks, the 
pharmacodynamics of such agents should also be taken into account. Recent blood 
transfusions may also affect the results of hemorheological measurements. 
 
Sampling should be done after overnight fasting between 08:00 to 10:00 in a 
quiet environment at normal ambient temperature. Blood withdrawal should be done 
after a 10 minute resting period and in a seated position. Sampling time and 
conditions should be described.  
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2.2. Sampling procedure 
 
2.2.1. Sampling site 
 
The usual sampling site is an antecubital vein but other sites are possible 
based upon the specific study protocol [38].  
 
2.2.2. Tourniquet application 
 
There is evidence for the significant effects of tourniquet application for blood 
sampling on the measured hemorheological parameters [36]. The effect of 
tourniquet application for the localization of a vein and insertion of the needle may 
continue for several minutes after the removal of the tourniquet [29]. The pressure 
exerted by the applied tourniquet and the length of tourniquet time may also influence 
this effect. It has been observed that the hemorheological parameters in samples 
were less affected if the sampling was done within 90 seconds after the application of 
tourniquet and without removing it [28]as compared to a procedure where sampling 
is done after the removal of tourniquet.  
 
2.2.3. Needles and withdrawal 
 
If the shear forces to which blood cells are exposed during sampling exceed 
certain limits cells can be damaged by such forces. The damage may range from 
minimal alterations in the mechanical properties of red blood cells to hemolysis due 
to disruption of the cell membrane. Additionally, high shear forces may induce 
platelet activation and coagulation of plasma, thereby resulting in clot formation in 
samples and altered levels of some plasma proteins (e.g., fibrinogen)[83].  Using 
narrow bore needles may increase shear forces during sampling [59]. The second 
important determinant of the shear forces is the negative pressure applied during 
withdrawal. Use of commercially available vacuum tubes provides the opportunity to 
apply a standard negative pressure during sampling.  
 
2.2.4. Anticoagulants 
 
Ethylenediaminetetraacetate (EDTA) and heparin are the most widely used 
anticoagulants in hemorheological studies. The anticoagulant used in 
hemorheological studies should not dilute the blood and the final concentration 
should be strictly controlled; the usual levels are 1.5-1.8 mg/ml EDTA and 14-15 U/ml 
heparin. Heparin has been demonstrated to influence hemorheological parameters to 
a greater extent than EDTA [6]and hence EDTA is preferred. 
 
2.2.5. Recommendation for sampling procedure 
 
Sampling should be done using sterile procedures, 21 G needles and vacuum 
tubes containing EDTA. A tourniquet can be used to locate the vein. Sampling should 
be done as soon as possible after the tourniquet application and, with the tourniquet 
in place, should be finished within 90 seconds. If possible, vacuum tubes from a 
single batch should be used within a given study and the manufacturer and batch 
number of the tubes should be reported. Differences from these conditions should be 
reported. 
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3. Storage and handling 
 
3.1. Storage 
 
It is well known that hemorheological properties of blood start to change with 
prolonged storage at room temperature [89]. Although the time course of these 
changes is slower if the samples are cooled to 4 °C, the safe storage time is still 
limited [89]. If the measurements can not be performed immediately or within 1 hour 
after sampling, the samples should be stored at 4 °C for no longer than 4 hours in 
order to be useful for most hemorheological parameters  The samples should not be 
frozen. The samples should be warmed to the measurement temperature prior to 
testing.  Note that changes of sample temperature may lead to platelet activation [17], 
and thus studies specific to platelet aggregation, adhesion or platelet-cell interactions 
should minimize such changes .   
 
Plasma viscosity is essentially unchanged for 24 hours after the sampling if 
the blood is left undisturbed, but may increase if the sample is frequently remixed. If 
the blood will reach the laboratory within six hours, the blood should be sent in its 
original container. When the specimen reaches the laboratory after six hours and for 
all postal specimens, the blood should be centrifuged and the plasma harvested. 
Both whole blood and plasma specimens should be centrifuged at 1,500 x g for 5 
minutes; in the absence of visible clotted material filtration of the plasma is not 
necessary. If tested on the same day, plasma may be left in contact with the pelletted 
RBC at room temperature, whereas for an over night delay it is recommended to 
transfer the plasma to a stoppered container; under sterile conditions it can be stored 
at room temperature for up to one week.  
 
3.2. Hematocrit adjustments 
 
Hematocrit adjustments may be necessary for blood viscosity and red blood 
cell aggregation measurements. This should be done by adding or removing the 
calculated amounts of autologous plasma to/from the samples. Plasma should be 
separated by gentle centrifugation (1,500 g, 5 minutes at room temperature). Use of 
a microcapillary centrifuge is recommended for hematocrit determinations before and 
after the adjustment.  
 
3.3. Washing of red blood cells 
 
All handling of red blood cells (e.g., washing, resuspending) should be kept to 
a minimum. If the measurement procedures require washing of red blood cells to re-
suspend them in a medium different than autologous plasma, this should be done by 
removing plasma and buffy coat after gentle centrifugation (1,500 g, 5 minutes at 
room temperature). Isotonic phosphate buffered saline (PBS; 290 ± 10 mOsm/L; pH: 
7.4) is recommended for washing procedure [54]. However, other isotonic buffers 
can be used and recommended for specific purposes (e.g., Hepes buffer for sickle 
RBC [55] or for studies where phosphate complexes with specific ions). Repeating 
the washing procedure two times is usually sufficient. It should be noted that the 
isotonic media used in washing procedures may influence the properties of blood 
cells. RBC morphology in the washed samples should be evaluated using a “dilute 
wet-mount” method: a thin well of grease (e.g., silicone vacuum grease) is applied 
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onto a glass slide, a dilute RBC suspension placed in the well and covered with a 
glass coverslip, and the RBC quickly viewed in the mid-plane of the well. RBC 
morphology should not be evaluated by only using a glass slide and coverslip since 
the two glass surfaces tend to cause crenation (i.e., the “glass slide” effect); the 
presence of about 0.1% albumin in the media greatly reduces this artifact. Proper 
control for any manipulation should always be included in the experimental protocol. 
The washing media and the details of the washing procedure should be reported.  
 
Hemoglobin oxygenation level has been demonstrated to influence RBC 
aggregation and deformability[90], and thus RBC suspensions for deformability and 
aggregation measurements should be fully oxygenated. This can be done by rolling 
the sample for 5 min in an air-filled test tube whose volume is at least five times that 
of the sample.  When exceptions to this requirement for oxygenation are necessary 
(e.g., studies of sickle RBC at low oxygen tension), the protocol and degree of 
deoxygenation (i.e., pO2 or saturation) should be indicated.   
 
3.4. Sample preparation for leukocyte studies 
 
Leukocytes are quite sensitive to their chemical environment and to the 
conditions existing during both isolation and measurement. It is desirable, where 
possible, to carry out analyses using whole or diluted fresh blood to avoid effects of 
isolation procedures. To limit leukocyte and platelet activation and interaction after 
withdrawal, theophylline may be added. Neutrophils can be isolated from blood using 
density gradients, and a number of studies have compared methods for their effects 
on neutrophil deformability, function or on markers of cell activation [68]. 
Nevertheless, numerous variants are in use and there is no generally accepted 
procedure. Media used in any procedure should be endotoxin-free as evidenced by 
culture-testing. It should be borne in mind that if preparation is carried out in a Ca++-
free environment and if neutrophils are suspended in Ca++-free media, spontaneous 
activation may follow re-introduction of Ca++. The practice of keeping neutrophils cold 
and then re-warming prior to testing is not recommended because of increased 
integrin expression and changes in mechanical and adhesive properties upon re-
warming [47, 68]. In the absence of a standard method, it is recommended that 
objective evidence of activation be sought (e.g., analysis of morphology or 
expression of the integrin component CD11b compared to values found in whole 
blood). 
 
 
4. Measurement of plasma viscosity, blood viscosity and blood viscoelasticity 
 
4.1. Viscometers  
 
Measurement of blood or plasma viscosity requires the use of viscometers, 
with the specific details of these instruments dependent upon the fluid being tested. 
Many blood viscometers are rotational, consisting of two concentric surfaces one of 
which rotates; their configuration is usually cylinder-in-cylinder (i.e., Couette) or cone-
plate, with the blood sample being sheared in the gap; tube viscometers are also 
utilized. The shear rate, which is a function of the rotational speed and system 
geometry, should be nearly constant in the gap. Most rotational viscometers operate 
at constant shear rates – one of the concentric surfaces is rotated at a constant 
 5 
speed and the shear stress generated is determined from the measured torque and 
the system geometry. Some rotational viscometers operate at constant shear 
stresses – one of the surfaces is driven by a constant torque, and the resulting shear 
rate is determined by measuring the rate of rotation. 
 
The viscosity of blood, more correctly termed the apparent viscosity of blood, 
is the viscosity of a Newtonian fluid (i.e., a fluid whose viscosity is independent of 
shear rate or stress) having the same resistance to flow at the same shear rate or 
shear stress. Thus apparent viscosity is understood to mean its rheological behavior 
under conditions where the blood is treated as a homogenous fluid and the formed 
elements (e.g., red blood cells, white blood cells) are tacitly ignored. Data obtained in 
systems with large flow geometries yield macro-rheological properties while small 
geometries provide micro-rheological characteristics; in general, data obtained in 
geometries of 200 µm or less are considered micro-rheological [26, 27].”  
 
 The apparent viscosity of blood (ηB) is calculated as: 
Apparent viscosity (ηB) = shear stress / shear rate = (K) (torque) / (rotational speed) 
 
K is a conversion factor dependent on the geometry of the viscometer system and is 
determined with the use of Newtonian fluids (e.g., oils of known viscosity) that cover 
the range of blood viscosity to be measured. 
 
The apparent viscosity of blood can also be measured in tube viscometers by 
determining the ratio of pressure drop (P) to volume flow rate (Q). The shear stress 
and shear rate both vary across the cross section of the tube, being zero at the tube 
center and maximum at the tube wall. The wall shear stress is calculated as: 
 
PR / 2L 
 
where R is the tube radius and L is the tube length.  
 
The wall shear rate for a Newtonian fluid is: 
 
4Q / πR3  
 
and is higher for non-Newtonian fluids such as blood, but still varies with Q. The 
“effective” apparent viscosity of blood is proportional to the P/Q ratio with a geometric 
constant K’ determined using Newtonian fluids. A more rigorous approach is needed 
to obtain the real wall shear rate and hence the real apparent viscosity at that shear 
rate. This approach is often termed the Rabinowitsch-Mooney- Weissenberg (RMW) 
method; in general, the RMW method results in a higher wall shear rate and a lower 
apparent viscosity [64]. 
 
The viscometer should ideally be able to operate over a wide range of shear 
rate or shear stress: for a constant shear rate instrument this should cover from 1 to 
at least 200 s-1, with an upper range of 300-400 s-1 so that the blood reaches its 
steady apparent viscosity, while for a constant shear-stress instrument the range 
should be 0.01-1 Pa. For routine clinical investigations it is recommended that two 
measurements of apparent viscosity be made, one at each end of the range. Thus a 
high shear measurement at 200-400 s-1 and a low shear measurement at 1 s-1 should 
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be made; shear rates approximating these values should be employed if they are not 
attainable in the instrument used. For a constant shear-stress viscometer, the values 
should be 0.01 and 1 Pa.  
 
Rotational viscometers may have a guard ring to prevent errors due to surface 
tension artifacts: alternatively, the investigator should assure that surface films 
artifacts are not affecting results, especially at low shear (see Potential Measurement 
Problems below). The components of the viscometer that are in contact with the 
blood sample should be readily accessible for cleaning following each blood test or 
disposable components should be used. The surfaces of the container/measuring 
system of the viscometer should be such that they can be subjected to post-cleaning 
sterilization with an appropriate disinfectant. 
 
A high degree of instrument sensitivity is required for measuring viscosity at 
low shear rates: a less than five percent coefficient of variation for a Newtonian fluid 
of comparable viscosity helps define the lowest measurable shear rate or shear 
stress. The instrument should be insensitive to the effects of vibration and air drafts 
or mounted on an anti-vibration table and fitted with a windscreen.  Temperature 
control systems (e.g., circulating water baths) should be used to maintain a desired 
set point. Additional energy input such as direct sunlight should be avoided in order 
to prevent undesired increases of temperature.    
 
It is usually desirable, especially in follow-up studies, to keep the volume of the 
blood sample small, and thus the design of the instrument should be such that 
measurements can be made on small volumes with the sensitivity and accuracy 
needed, especially at low shear. In rotational instruments, it is important to have 
precise coaxial alignment of the two surfaces. As mentioned below, RBC syneresis 
can occur at low shear, thereby yielding a time-dependent torque reading with a rise 
to a peak followed by a decline. However, if the dynamic response of the torque 
measuring system is slow, such a peak may not be evident and hence the measured 
torque will be too low; the investigator should have a knowledge of the dynamic 
characteristics of the viscometer (i.e. the time required for the torque signal response 
to reach a steady value both for a standard fluid and for blood samples). 
 
4.1.1. Steady Shear or Oscillating Shear Conditions  
 
Currently most basic science and clinical hemorheology studies employ one or 
more steady shear rates to obtain the apparent viscosity of blood; plots of shear 
stress vs. shear rate or apparent viscosity vs. shear rate are useful for examining the 
non-Newtonian flow behavior of blood or RBC suspensions. However, there is 
another approach for examining blood rheology: subject blood to oscillatory or other 
time-dependent flow. Normal human blood at physiological hematocrits exhibits both 
a viscous and an elastic response under such conditions and hence exhibits 
viscoelastic flow behavior. Using this approach it is possible to determine energy 
stored (i.e., elastic) and energy lost (i.e., viscous) during the deformation. 
Measurements of the magnitude and phase of sinusoidal oscillatory shear stress and 
shear rate or shear strain provide direct access to the conventional rheological 
parameters for a viscoelastic fluid: 1) viscosity and elasticity η' – i η"; 2) storage and 
loss moduli G'+ i G"; 3) Maxwell relaxation time Tm. The aggregation tendency and 
deformability of RBC have a strong influence on the blood viscoelasticity, and hence 
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the shear rate profile reveals the integrated effects of aggregation tendency, 
aggregate strength and dynamic deformability. 
 
Both the theoretical basis and experimental results of viscoelasticity have 
been published and an overview of this topic has been presented by Thurston and 
co-workers [88]. Methods of measurement include use of oscillatory flow in 
geometries such as cylindrical tubes, Couette cup and bob and cone-plate; non- 
oscillatory flows have also been used. Each of these methods requires careful 
consideration of the dynamics, geometry and sensitivity of the testing system, 
especially since many commercial viscometers are usually designed for industrial 
material having greater viscous and elastic properties vis-à-vis blood. As with steady 
shear studies, viscoelastic measurements are subject to the potential measurement 
problems described below. 
 
4.2. Measurement of plasma viscosity 
 
Plasma viscosity is an important factor influencing whole blood viscosity and is 
directly correlated with the concentration of proteins and lipids [51]; changes in 
plasma viscosity may occur in both acute and chronic conditions [1, 10, 56]. There 
are several commercially-available instruments that use different principles and 
operating techniques (e.g., cone-plate, Couette, rolling ball, tube) but which, if used 
correctly, yield identical values. Almost all plasmas have Newtonian flow behavior, 
yet may appear to have shear-dependent viscosity due to surface film artifacts (see 
section 4.4). Thus, moderate to high shear rates or pressure gradients are employed 
in order to minimize or eliminate the surface film artifact. In some rotational 
viscometers, high shear rates may generate secondary flow resulting in a 
erroneously high values. Temperature control, usually at 37 °C, is necessary since 
plasma viscosity changes by about 2% per degree Celsius.     
 
4.3. Measurement of blood viscosity 
 
Hematocrit profoundly affects the rheological behavior of blood and RBC 
suspensions and thus a decision must be made regarding measurements on native, 
as-drawn blood versus on samples adjusted to a fixed hematocrit. Clinical studies 
often utilize the native hematocrit since it tends to reflect in vivo conditions, whereas 
studies designed to evaluate RBC aggregation and deformability by viscometry 
require hematocrit adjustment to allow comparisons. Hematocrit can usually be 
determined via automated hematology analyzers, but in the case of rigid cells (e.g., 
deoxygenated sickle erythrocytes, heat-treated cells) it should be confirmed by the 
microhematocrit method (10,000 – 15, 000 g, five minutes); when using extremely 
rigid RBC (e.g., aldehyde fixed) the microhematocrit can be corrected for trapped 
plasma.   
 
4.3.1. Measurement temperature  
 
Blood viscosity varies inversely with temperature and viscometers must be 
capable of maintaining the sample temperature constant at the desired temperature 
with a maximum error of ±0.5º C. Pre-warming of the blood sample and instrument 
sample container to the working temperature is suggested. When using an external 
water bath with a circulator, the connecting tubing should be sufficiently short and 
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insulated to insure that the temperature of the blood sample itself is at the intended 
level. A direct measurement of the working temperature of the test sample is a 
desirable instrument feature. It is recommended that blood viscosity measurements 
be made at 37ºC. Measurements at lower temperatures may be required for the 
study of some patients (e.g., Raynaud’s phenomenon) or for studies specific to 
temperature effects.  
 
4.3.2. Measurement technique 
 
The blood sample container and measuring system should be clean and dry 
prior to each measurement. RBC aggregation at low shear may cause erythrocyte 
syneresis and sedimentation, and thus at low shear rates the blood sample must be 
well-mixed immediately prior to each shear rate measurement. It is generally not 
acceptable to use a scanning method in which shear is progressively and 
continuously increased or decreased since at lower shear rates there may be 
insufficient mixing: without adequate mixing the results are invalid. Any deviation 
from this approach should be stated when reporting results. Note that RBC 
aggregation and the attendant problems of low-shear viscometry are often enhanced 
in pathological samples, and thus erythrocyte sedimentation may present a problem 
especially in a tube viscometer. 
 
Viscosity results for native whole blood samples from patients should be 
compared with those from normal, gender and aged matched individuals made at the 
same shear rate and temperature. If it is desired to assess whether any change in 
apparent viscosity is attributable to factors other than hematocrit, the patient’s blood 
viscosity should be compared with the results obtained in normal blood at a 
comparable hematocrit. For this latter comparison each laboratory may prepare its 
own reference range relating apparent blood viscosity to hematocrit using normal 
blood whose hematocrit is adjusted to cover a 20-70% range. As a quality control 
check, reference ranges should be re-determined periodically in each laboratory. 
 
4.4. Potential Measurement Problems  
 
It is necessary to consider some difficulties and potential artifacts associated 
with rheological measurements on blood, plasma and related fluids. Three properties 
of these materials can lead to problems in measuring rheological behavior: 1) The 
plasma proteins are surfactants and form a protein layer or film at fluid-air interfaces; 
2) The erythrocytes are denser than plasma; 3) At low shear rates, RBC tend to 
aggregate. 
   
4.4.1. Surfactant Layer 
 
The surfactant layer formed by plasma proteins at the fluid-air interface has 
mechanical strength and is a semi-rigid film. Consequently, the pressure drop across 
such interfaces, as usually exists in a capillary viscometer, is not zero. The surfactant 
layer can also transmit significant torque to the torque-measuring element in 
rotational viscometers. In general, this effect is important only for plasma and serum 
or for low-hematocrit RBC-plasma or RBC-serum suspensions; at normal or high 
hematocrits, the additional torque is only a small percent of the total and can be 
essentially ignored. However, an unfortunate result of this additional torque is the 
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artifact of non-Newtonian flow behavior for normal human plasma. Procedures to 
minimize or eliminate the influence of the protein layer depend on the type of 
viscometer used: for capillary viscometers, use fluid filled pressure transducers that 
connect to sample reservoirs below the fluid-air interfaces, or obtain pressure drop 
and flow rate data using two capillaries of the same diameter but significantly 
different lengths. In the case of rotational viscometers, one approach is to insert a 
“guard” ring through the interface, thereby isolating the torque-sensing element from 
the film-associated drag. Note, however, that the guard ring must rotate at the same 
angular velocity as the torque-measuring element of the viscometer, and is thus not 
useful for viscometers in which the element both rotates and senses torque. Note 
also that the need to employ these approaches will depend on the details of the 
viscometer design and may not always need to be utilized. 
  
4.4.2. Red Blood Cell Sedimentation  
 
RBC sedimentation is slow for individual cells, and for an individual RBC in 
plasma is only about 0.13 µm/minute or 0.08 mm/hr. If the suspending medium does 
not promote marked RBC aggregation, and if the hematocrit is 15% or greater, the 
presence of neighboring red cells causes the settling to be hindered and hence 
slower. RBC aggregation greatly increases the sedimentation rate since the settling 
rate of particles is dependent on the square of the particle size. A typical, steady, 
hindered settling rate for 40% hematocrit normal human blood is about 200 µm/min 
or 10 mm/hr. Usually, sedimentation in viscometers is not a significant problem if the 
wall shear rate is above several inverse seconds. However, at lower shear rates, the 
effect of erythrocyte sedimentation must be considered, especially for horizontal tube 
and cone-and-plate viscometers. For example, in cone-plate viscometers a cell-poor, 
lower viscosity layer can develop at the upper element; if torque is sensed by this 
upper element then torque readings and hence calculated viscosity values are too 
low. RBC aggregation may be greatly enhanced in certain pathologic states (e.g., 
diabetes, myocardial infarction), thus making this process of particular importance 
when measuring such samples [62]. 
 
4.4.3. Red Blood Cell Syneresis  
 
In addition to sedimentation, RBC aggregation also causes red cell syneresis, 
which is the partial separation of RBC from their suspending medium as they 
aggregate. This process leaves layers of cell-poor plasma at the walls of viscometers 
of all types. If using a concentric cylinder viscometer filled with well-mixed and well-
stirred blood, the effects of syneresis are seen very soon after starting the viscometer 
at a constant low shear rate of about 2 s-1 or less. In this case, the torque first rises 
from zero to a peak, then decays in an exponential manner with time, finally reaching 
a steady value after approximately 30 minutes. This time-dependent torque response 
is due to the startup of the fluid motion at very short times, syneresis of the 
erythrocytes away from the viscometer surfaces at all times, and finally, at very long 
times, sedimentation effects. Note that essentially all investigators agree that using 
the final steady-state value of torque is incorrect since this value is the result of fully 
completed syneresis plus some variable degree of sedimentation: its use results in 
shear stress and viscosity values that are too low. Two different methods have been 
proposed for assigning the correct torque at shear rates below about 2 s-1: one uses 
the peak torque value while the other extrapolates the exponentially decaying torque 
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data back to zero time. Using normal blood the two methods diverge at shear rates at 
and below 1 s-1, with the peak method often leading to an artifact of Newtonian flow 
at very low shear; the results are usually coincident at higher shear. Note that 
syneresis can also affect vertical tube viscometers at low shear rates, in that a cell-
poor layer forms at the tube wall thereby decreasing resistance to flow, whereas if the 
viscometer tube is horizontal RBC sedimentation tends to increase flow resistance. 
     
4.5. Expression of results 
 
Values for apparent blood viscosity at 37 0C should be given in milliPascal 
seconds (mPa.s), which is equal to the older term “centiPoise” (cP), at a stated shear 
rate (or shear stress) and hematocrit. For clinical purposes, the laboratory reference 
range at 37 0C should be given for each of the shear rates (or shear stresses) 
reported.   
 
 
5. Red blood cell aggregation 
 
Under static conditions, RBC in normal human blood form loose aggregates 
having a characteristic face-to-face morphology similar to a stack of coins; such 
aggregation is frequently referred to as rouleaux formation [71, 76]. Moreover, given 
sufficient time and a non-confining space, individual rouleaux can cluster, thereby 
forming three-dimensional structures. The attractive forces involved are relatively 
weak and aggregates can be dispersed by applied shear and during flow. This 
process is reversible so that aggregates reform under quiescent conditions. RBC 
aggregation increases low shear blood viscosity and affects micro-vascular flow 
dynamics [49] and can be markedly enhanced in several clinical states. 
 
Factors affecting RBC aggregation can be divided into intrinsic and extrinsic 
factors:1) Extrinsic factors include levels of plasma proteins (e.g., fibrinogen, 
macroglobulins), hematocrit and shear rate; 2) Intrinsic factors include RBC shape, 
deformability and membrane surface properties. Extreme changes from the normal 
biconcave shape and/or decreased cellular deformability will decrease aggregation. 
RBC surface properties and structure, including surface charge and the ability of 
macromolecules to penetrate the membrane glycocalyx, greatly affect aggregation 
for cells suspended in a defined medium (e.g., compatible plasmas, polymer 
solutions). Thus, RBC cellular properties determine the cell’s intrinsic tendency to 
aggregate and are the basis for the term “RBC aggregability”. Aggregability is 
increased if, for the same suspending medium, the test RBC aggregate more than 
control cells or cells from a different blood donor; the converse finding indicates 
decreased aggregability.   
 
5.1. Methods 
 
Various approaches and methods have been employed to assess RBC 
aggregation, and there are currently commercial instruments with the ability to 
provide information relevant to one or more aspects of aggregation. However, there 
are no “standard” or “calibrator” suspensions for RBC aggregation and thus each 
method may yield one or more parameters that are possibly unrelated to those 
obtained by another technique.  
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5.1.1. Measurement of light transmission or light reflection through/from RBC 
suspensions   
 
This technique is based upon the increase of light transmission (LT) through 
[15] or decreased light reflection (LR) from [42] a RBC suspension that occurs 
when individual cells aggregate into rouleaux or rouleaux-rouleaux complexes; gaps 
in the suspending medium between the aggregates allow more light to pass through 
the RBC suspension or less light to be reflected. Recording of LT or LR for further 
analysis is often termed syllectometry. Devices that employ this approach usually use 
a transparent cone-plate system, parallel rotating surface(s), Couette or a rectangular 
flow chamber geometry. 
 
Different indices of aggregation can be measured based on both light 
transmittance and reflectance: 
 
a) RBC Aggregation at stasis: A blood sample is first briefly sheared at a constant 
high shear rate, usually in the range of several hundred s-1, to disperse all pre-
existing aggregates. The shear rate is then abruptly decreased to zero following 
which light intensity is integrated for a fixed time, usually in the range of a few 
seconds or minutes. The numeric value resulting from this integration serves as one 
measure of aggregation, with its absolute value dependent on both aggregation 
tendency and integration time. Other indices that may be calculated using the 
recorded time course of LT or LR can be found elsewhere [15, 42]. 
 
b) RBC Aggregation at low shear: The blood sample is first briefly sheared to 
disperse all pre-existing aggregates, following which the shear rate is abruptly 
reduced to a low fixed shear rate (e.g., 3 s-1) and the light is integrated over a fixed 
time. The numeric value resulting from this integration is again a measure of 
aggregation. Note that this method reflects the extent of aggregation under 
conditions at which low fluid shear promotes cell-cell contact. The rationale for the 
low shear measurement evolved from earlier studies in which a “flow to stasis 
aggregation ratio” (FSAR) was calculated (i.e., ratio of the extent of aggregation at 
low shear to that at stasis [91]. 
 
c) RBC Aggregation kinetics: Several kinetic parameters can be extracted from digital 
recordings of the time course of LT or LR, including two exponential time constants 
and an overall half-time for aggregation. 
 
d) RBC disaggregation shear rate or stress: The shear rate just sufficient to disperse 
existing aggregates and to prevent aggregate formation, without causing cell 
deformation, is determined by applying different shear rates to a blood sample and 
recording steady-state LT or LR as a function of applied shear rate. LT is greater at 
low shear due to aggregate formation and also greater at high shear due to cell 
deformation; LR is opposite in behavior (i.e., decreased with increased aggregation). 
The resulting data are fitted by non-linear regression analysis, with the 
disaggregation shear rate determined as the shear rate with minimal LT or maximal 
LR; this shear rate is sometimes referred to as the threshold shear rate. The RBC 
disaggregation shear stress can be obtained by multiplying the disaggregation shear 
rate by the viscosity of the blood sample measured at the same shear rate. 
 12 
 
5.1.2. Microscopic indices of Red Blood Cell Aggregation 
 
Microscopic aggregation indices are direct methods for assessing aggregation 
at stasis and at low flow[5]. For example, a dilute RBC suspension (e.g., ≈ 1% 
hematocrit) of known cell count is placed in a standard hemocytometer chamber and 
left undisturbed for a defined period (e.g., 5 or 10 min). Several areas of the chamber 
are then recorded by video microscopy following which the number of cellular units 
(i.e., a single mono-dispersed cell or a single cellular aggregate) per unit volume is 
counted. The microscopic aggregation index is then calculated as the ratio of (total 
cell count per volume) / (number of cellular units per volume), and increases with the 
extent of aggregation. In addition, the geometry of the aggregates can be assessed 
for perimeter, area and several shape factors. RBC aggregation can also be 
investigated by microscopic observations under various flow conditions (e.g., parallel 
plate, counter-rotating surfaces) [5]. These methods can be combined with 
computerized image analysis methods to improve the accuracy and efficiency of data 
collection. 
 
5.1.3. Erythrocyte sedimentation rate 
 
The sedimentation behavior of RBC suspensions in defined vertical circular 
geometries has been used for decades as an index of health and of the presence of 
plasma proteins which promote RBC aggregation. In very dilute suspensions, the rate 
of a spherical particle’s sedimentation increases with the square of its radius (i.e., 
Stokes’ settling). This concept has been extended to the crowded environment of 
blood or RBC suspensions such that an increased settling rate or extent is 
associated with increased RBC aggregation. Techniques to determine the 
erythrocyte sedimentation rate (ESR) include the Wintrobe and Westergren methods 
in which the distance fallen by the cells is determined at the end of a 60 min period of 
settling. Either manual or automated methods may be used to obtain additional 
detailed information about the process, including the time required to initiate settling 
and the true steady-state rate of settling; ultrasound methods have also been 
employed to follow the settling process.   
 
5.1.4. Low shear viscosity 
 
In general, blood viscosity at shear rates below about one to five inverse 
seconds increases with RBC aggregation, and thus low shear apparent viscosity is 
used as an index to the intensity of aggregation; the ratio of low to high shear 
viscosity has also been utilized. Techniques and precautions for low shear blood 
viscosity measurements are discussed in Section 4.4.  It is important to note a 
potential artifact possible with this method: small decreases of RBC deformability can 
increase low shear viscosity, even for RBC in plain buffer, but may not affect high 
shear results [12]. Given the unaltered high shear viscosity and elevated low shear 
viscosity, one could incorrectly infer enhanced RBC aggregation.  
 
5.1.5. Ultrasound backscattering 
 
Individual RBC and RBC aggregates behave as ultrasound scattering objects, 
with the extent of backscattering related to the volume of the cell or aggregate. The 
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backscattering coefficient is commonly used to characterize ultrasound scattering by 
blood and RBC suspensions, with the magnitude of the coefficient increasing with the 
degree of aggregation; for aggregating suspensions, the coefficient decreases with 
increasing shear rate [24].   
5.2. Measurement conditions 
 
Note that all current techniques used to measure RBC aggregation are 
sensitive to hematocrit and the properties of the suspending medium (e.g., density, 
viscosity) as well as to the levels of pro-aggregating plasma proteins: 1) light 
transmission and reflection methods have a biphasic response to hematocrit with 
some indices decreasing with increased or decreased hematocrit; 2) microscopic 
methods are unreliable at hematocrit extremes; 3) ESR varies inversely with 
hematocrit and is decreased by increased medium density and viscosity; 4) low shear 
viscosity is extremely sensitive to hematocrit. Thus, while measurements using native 
blood may be potentially useful for some clinical evaluations or for large-scale 
population studies, experimental studies intended to specifically measure RBC 
aggregation should utilize RBC suspensions adjusted to a fixed hematocrit. Either 
40% or 45% are recommended, except for microscope-based methods which require 
a lower hematocrit. Aggregation studies for RBC suspended in various polymer or 
protein solutions should substitute the solution for buffer during the second wash. For 
the measurement of RBC aggregability it is recommended to use fixed 
concentrations of dextran (e.g., 3 mg/ml 70 kDa, 0.5 mg/ml 500 kDa), but other 
polymers may also be suitable. If available, the ratio of weight-average to number-
average molecular weight (i.e., Mw/Mn) for the polymer fraction should be stated as 
well as the viscosity of the polymer solution. 
 
RBC suspensions should be fully oxygenated, especially if they are used for 
aggregation measurements using LT and LR. This can be done by equilibrating the 
sample with ambient air in a test tube having a large volume compared to the sample 
size (e.g., 1/20). It is recommended to carry out all measurements at 37 °C.  
 
5.3. Precautions 
 
It is important to recognize the possibility of potential artifacts or challenges 
associated with various methods. Some of these include: 1) Assuming that a shear-
based method applies sufficient shear stress to initially fully disperse all aggregates 
for suspensions having very high aggregation, since failure to disperse pre-existing 
aggregates usually results in falsely low indices; 2) Assuming that elevated low shear 
viscosity always indicates increased aggregation, since small decreases of RBC 
deformability will increase low shear viscosity, even for RBC in simple buffer, but may 
not affect high shear results; 3) Increased suspending phase viscosity due to greatly 
increased levels of plasma proteins (e.g., macroglobulins) or to added polymers will 
tend to decrease the RBC sedimentation rate, retard the kinetics of RBC aggregation, 
and increase fluid shear stress at a given shear rate; 4) The morphology of RBC 
aggregates may differ depending on the polymer or protein causing aggregation, with 
macroglobulins and some large polymers resulting in the formation of clumps rather 
than face-to-face rouleaux [84]. 
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The extent to which any or all of the abovementioned potential problems affect 
a specific method should be considered. Thus the following procedures are 
recommended to validate aggregation results: 1) Examine RBC morphology in the 
suspending medium to determine alterations from the normal biconcave shape (e.g., 
crenated, cupped); 2) Examine the morphology of aggregates to determine their 
shape (e.g., rouleaux, clumped, smooth spheres), with clumped or spherical forms 
indicating intense aggregation and the possible need for higher than normal stress 
levels to disperse such aggregates; 3) As practical, determine light transmission or 
reflection from a RBC suspension as a function of increasing dis-aggregating shear 
rate in order to assure that this rate is sufficient to fully disperse aggregates.  
 
5.4. Interpretation of the results 
 
Parameters reflecting the extent of RBC aggregation are usually 
dimensionless and are thus usually not comparable between instruments, but within 
an experimental study using a single method, comparisons are most likely valid if the 
hematocrit is adjusted to a constant value.  However, kinetic indices of RBC 
aggregation such as half-time of aggregation have standard dimensions (e.g., 
seconds) and therefore should be comparable.  Note that it is now clearly evident 
that donor-to-donor differences of “cellular factors” can affect aggregation, even for 
normal RBC in a defined aggregating medium (i.e., RBC “aggregability”).  Thus 
variations of results for a given experimental protocol may reflect biological variability  
as well as the characteristics and precision of a particular instrument.  
 
 
6. Measurement of Red Blood Cell Deformability 
 
The ability of RBC to deform in response to an applied force (i.e., RBC 
deformability) is required for their normal passage through the capillaries of the 
microcirculation and the splenic sinusoids. Erythrocyte deformability also influences 
blood viscosity in wide-bore vessels. The high deformability of the normal erythrocyte 
is a consequence of its low intracellular (cytoplasm) viscosity, its excess of surface 
membrane area in relation to cell volume (S/V ratio) and the viscoelastic properties of 
its cell membrane. Loss of deformability may arise from impairment of any one, or a 
combination, of these properties. Similarly, the methods and instruments available for 
measuring erythrocyte deformability may be sensitive to these properties to differing 
degrees. For measurement of their deformability, erythrocyte suspensions can either 
be sheared in large geometry systems (e.g. viscometry or laser diffraction 
ellipsometry, also called ektacytometry) or made to traverse narrow channels (e.g. 
micro pipettes, micro channels or filter pores). 
 
6.1 Methods 
 
6.1.1 Bulk filtration methods 
 
Erythrocyte filtration methods were previously the most widely utilized 
approach to the assessment of RBC deformability. Because of the apparent simplicity 
of the method many variations have been developed. In all cases the ability of 
erythrocytes to pass a filter is measured, either by the time required for passage of a 
certain volume of erythrocyte suspension or by the pressure-flow relationship. 
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Polycarbonate membranes with a pore diameter of 3-5 µm were usually used. The 
geometric characteristics of the filter, especially the mean pore diameter, the total 
number of pores and their distribution across the membrane surface, are of critical 
importance for the final outcome. It is therefore essential to perform comparable 
filtration measurements of different samples with the same batch of membranes.  If 
possible, it is preferred to use the same membrane that is cleaned between 
measurements. Note that since filtration results are functional assays and can be 
affected by many factors, it is recommended to use the term filterability for these 
measurements [40, 41]. 
  
The various filtration systems used gravity, positive pressure or negative 
pressure driven filtration. A major disadvantage of these bulk filtration systems is that 
due to the relatively high stresses employed, minor deformability changes often 
remain undetected. In addition, pore blockage by the more rigid leukocytes, platelet 
micro aggregates or even rigid erythrocytes can be a complicating factor [75]. 
Further, techniques used for the preparation of a pure erythrocyte suspension carry 
the inherent risk that RBC sub-populations may be selectively removed. Changes in 
filterability could result from a change in deformability of either the whole cell 
population or a subpopulation. Finally, intrinsic erythrocyte factors (e.g., MCV for 
smaller diameter pores, MCHC for larger diameter pores), and cell morphology may 
affect the final outcome.  
  
6.1.2. Pore Transit Analysis  
 
Passage of individual RBC through individual cylindrical pores can be 
monitored by recording the electrical conductance across a special filter containing 
only about 30 pores of well-defined geometry[57]. Dilute RBC suspensions are 
filtered through these “oligopore filters” using only a few centimetres of water 
pressure gradient. The resulting resistive pulses are digitally recorded and analyzed 
to obtain several parameters reflecting various aspects of RBC passage through the 
pores [7]. Filters with different pore sizes can be used and the cell size-pore size 
ratio determines the sensitivity of the method to alterations in deformability [9]. 
While offering the ability to detect subpopulations of cells with differing deformability, 
commercial versions of this technology are, unfortunately, not currently available.   
 
6.1.3 Laser diffraction ellipsometry or ektacytometry  
 
This technique is based on shear-induced elongation or deformation of RBC 
into ellipsoid-like shapes. Shear stress is applied to a dilute erythrocyte suspension 
by a rotational cylindrical Couette or plate-plate system, by flow between parallel 
plates or by tube flow. Regardless of the geometry employed, the shear stress acting 
on the cells is the product of local shear rate times the suspending medium viscosity. 
A laser beam, passing through the cell suspension at a right angle relative to the flow 
vector, is diffracted by the cells. The pattern of diffracted light is analyzed either via 
measuring light levels at defined locations or by image analysis. The results are 
commonly expressed as an elongation index (EI) or a deformation index (DI): both 
reflect the aspect ratio of the ellipse as (length-width)/(length+width) and increase 
with cell deformation.  
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By subjecting normal erythrocytes to a progressive increase in shear stress, 
an S-shaped deformation curve (i.e., EI versus shear stress) is obtained. Additional 
specialized testing methods include: 1) for mainly diagnostic purposes, RBC 
elongation, at a constant high shear stress, is measured while the osmolality of the 
suspending medium is progressively increased from ~100 to 450 mosmol/kg, 
generating an EI-osmolality pattern often referred to as an osmoscan [82]; 2) 
continued exposure of either RBC or RBC ghosts to high shear stress can be used 
as an erythrocyte stress test, mainly reflecting cell membrane fragility. The latter 
effect for RBC can be analyzed by measuring EI continuously during the stress 
experiment [21] or by comparing cell deformability before and after the application 
of shear stress [21, 58]. Studies using resealed RBC ghosts involve measuring EI 
over time at constant stress to study membrane fragmentation and thus membrane 
stability [21].  
 
6.1.4. Micropipette aspiration 
 
Since its development in the early 1950’s, micropipette aspiration of 
erythrocytes has been a useful experimental technique to provide precise, 
quantitative information on the rheological properties of individual erythrocytes. 
Several uses of micropipettes are possible and include: 1) measuring membrane 
elastic shear modulus and area compressibility modulus by partial aspiration of a 
small portion of membrane into 1-2 µm pipettes; 2) measurement of overall cell 
deformability by aspirating the entire cell into 3-5 µm pipettes; 3) determining the time 
constant for RBC shape recovery, and hence membrane surface viscosity, by 
extending then releasing a cell point-attached to a surface; 4) determination of cell 
volume and membrane surface area by aspirating cells into small pipette to form a 
spherical outer portion and a tongue within the pipette. However, such 
measurements on single erythrocytes are tedious, time consuming and require a high 
degree of technical skill. Thus, while micropipette methods are invaluable for basic 
science studies, the technique has remained of limited clinical value.  
 
6.1.5. New and emerging single cell techniques: micro flow devices, optical traps, 
stretchers and tweezers 
 
Recent advances in nanotechnology, molecular biomechanics and micro flow 
techniques have led to the development of a new suite of techniques for quantifying 
erythrocyte deformability, including optical traps, stretchers and tweezers. Micro flow 
channels allow real-time mechanical manipulation and analysis of single erythrocytes 
at the micro- and nanometer level and with nano- and pico-Newton force resolution. 
At present, however, these techniques are still highly experimental and precise 
control and measurement of flow (i.e., shear stress) in such miniature devices 
presents a problem.  
 
6.1.6. Viscometry, Tk factor calculation 
 
This bulk viscosity method for estimating deformability was cited in the prior 
Guidelines. However, the Tk parameter is also affected by plasma viscosity and 
hematocrit, and is thus is not currently recommended for erythrocyte deformability 
assays.  
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6.2. Measurement conditions for ektacytometry  
 
Ektacytometry is currently the most widely used technique for the 
measurement of RBC deformability; measurement conditions, precautions, 
expression of results and interpretation issues for this method are discussed below.  
 
Based upon many literature reports, several experimental conditions are 
required in order to avoid measurement problems: 1) Dilution of whole blood or cell 
suspensions in isotonic solutions of polyvinylpyrrolidone (PVP) or dextran in buffer to 
achieve a hematocrit of about 0.2 to 0.3%; 2) Use of a PVP or dextran medium 
having a viscosity of about 30 mPa.s at 37 °C since below this level cell deformation 
at constant shear stress is affected by medium viscosity; 3) Measurement at 37 °C 
since it has been observed that a given impairment in erythrocyte deformability, 
under certain experimental conditions, could only be detected at 37 0C [11]. 
 
The shear stress range to be used depends on the ultimate goal of the 
measurements: 1) For comparisons of EI measured at specific levels of shear stress 
measurements should be done in the mid-range (e.g., ~3 Pa); 2) If the EI-SS curve 
will be parametrized, SS range should be extended to cover the level sufficient to 
reach the maximum EI (see below; section 6.3).  
 
6.3. Expression of results 
 
Deformation data as an elongation index (EI) are usually presented graphically 
as a function of shear stress, with EI having a value for normal cells of about 0.6 at 
50 Pa. Tabular results at one or more selected stress levels are also appropriate. EI 
values taken from deformation curve at about 3 Pa are more sensitive for changes in 
deformability but have also a higher CV than values at higher levels (e.g., 50 Pa). In 
order to define one or more global parameters of deformability, the entire data set 
can be parameterized. Two approaches have been described to obtain the maximal 
deformation at infinite shear (EI max) and the shear stress at one-half of this 
maximum (SS ½): 1) by empirical non-linear curve fitting [18]; 2) by linear 
regression using a method analogous to a Lineweaver-Burk plot (i.e., inverse of 
shear stress versus the inverse of EI) [13]. If the Lineweaver-Burk plot is used to 
calculate these parameters, EI values measured at SS below 1 Pa should not be 
included due to the significant deviations from the linear model. The upper value of 
SS used for measurements should not be below 50 Pa for such calculations. Osmotic 
scan results are expressed by several osmolality values defined by the deformation-
osmolality curve: hypo- (Omin), iso- (Omax) and hyper (Ohyper) osmotic conditions [23]. 
Stress test results for intact RBC report deformability prior to and after a period of 
high stress, with membrane fragility (i.e., fragmentation) for ghosts expressed as the 
half time for decay from maximal deformation during the application of a given stress 
 
6.4. Interpretation of results 
 
While the range of EI values for patients and healthy individuals is usually 
relatively small, at least in the presence of a functioning spleen [8], there are results 
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indicting the clinical potential of assessing RBC deformability by ektacytometry [44]. 
In addition to statistical analysis of data at selected shear stress levels, other 
approaches are possible: 1) examining the initial slope and the deformation index at 
high stress, since the slope primarily reflects membrane mechanical characteristics 
while high stress value mainly related to the cell’s surface area to volume ratio and to 
intracellular viscosity or MCHC [22]. Interestingly, deformation values at isotonic 
conditions are relatively insensitive to cell volume over a range of MCV [43]; 2) 
using the two parameters obtained from either one of the two curve fitting methods 
(see section 6.3).  
 
All ektacytometric techniques described have in common that the average 
deformability of all erythrocytes in the test sample is measured. However, in the 
presence of very rigid cells (e.g., chemically fixed discocytes, cells from subjects with 
sickle cell disease), the diffraction image has a central circular component 
superimposed on the normal ellipsoid shape; estimation of the EI is thus adversely 
affected. As an alternative to testing sub-fractions of the RBC population, a 
deconvolution approach has been described[86]. When a detailed cell-by-cell 
analysis is required (e.g., infected RBC in malaria), direct observation in defined 
shear fields is possible using microscopy plus transparent shearing systems such as 
a counter-rotating rheoscope[33] or cells attached to a surface in a flow chamber 
[78]. 
 
 
7. White blood cell rheology 
 
The rheological factors influencing the circulation of white blood cells (i.e., 
leukocytes) can be broadly divided into: 1) resistance to deformation in response to 
hemodynamic forces; 2) adhesiveness to the vessel wall. Both are influenced by the 
activation of leukocytes in response to physiological and pathological stimuli, and 
changes in both can cause vascular obstruction and damage such as seen in 
vascular inflammatory disorders. The rheology of neutrophils has been studied more 
widely than rheology of other leukocyte subsets. An important caveat is that the 
activation state and hence the rheological properties of neutrophils are highly 
sensitive to preparative procedures. At the same time, it is changes in this state that 
are of interest and likely to be reflected in clinical measurements. Lymphocytes 
appear less labile in their behavior, and while monocytes are highly reactive, 
rheological studies on these cells have been rare. Much of what follows relates to 
neutrophils, but the measurement systems and principles should apply to other 
subsets. Methods for preparing samples are considered in Section 3.4; this section 
concentrates on analysis of resistance to deformation and adhesiveness. 
 
7.1. Measurement of leukocyte deformability and related parameters 
 
7.1.1. Suspension filtration 
 
Filtration techniques have been the most readily available and widely used 
methods for testing resistance to flow of leukocytes, and have been used in a range 
of clinical studies (see [48, 66]for reviews). Use of whole or diluted blood is possible 
with some filtration systems [30]. In the case of isolated neutrophils, results 
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correlate with morphological activation [67]or are sensitive to agents which induce 
activation [68].  
 
In general, the flow rate is measured for a cell suspension or blood suspension 
passing through a filter with pores of 5µm or 8µm diameter under the action of a 
constant driving pressure [48, 66]. Alternatively, a constant flow rate may be used, 
and pressure monitored. Flow-versus-time may be used to assess achievement of a 
steady state and the tendency to block pores, reflecting the flow resistance of the 
main population or a resistive sub-population. Mathematical models of the flow 
curves may allow detailed analysis of sub-populations of the flowing leukocytes [30, 
69]. In principle, filtration methods do not necessarily distinguish between adhesive 
properties, geometric properties and cytoplasmic properties, or clearly identify the 
contribution of recognizable sub-populations. The use of Ca++-free media should, 
however, minimize contributions from adhesion.  
 
7.1.2. Pore transit analysis 
 
Modified filtration techniques can measure the properties of individual cells, 
rather than population averages, by using dilute suspensions and electronic sensing 
of transit through special polycarbonate filters termed oligopore filters (see section 
6.1.2 above) [74]. The time taken for individual leukocytes to pass through 8µm 
diameter pores is measured under constant pressure [74]. This approach has the 
advantage that a frequency distribution of cell properties is attained for about 1000 
cells and there is the potential to detect abnormal sub-populations of cells, although 
trapped cells and some very slow-flowing cells may not be detected [20]. 
 
7.1.3. Micromanipulation 
 
Detailed information on individual leukocytes can be obtained by 
micromanipulation [20, 35, 70]. Structural viscoelasticity may be tested by partial 
aspiration into a micropipette with a diameter about 2 µm [35], or the overall 
resistance of a whole cell to entry into 4-8µm pipettes can be measured [70]. Few 
clinically-related studies have used this complex and time-consuming methodology. 
Activated neutrophils are, however, clearly more rigid and the effects of specific 
pathological agents may be studied [20]. In these methods, cation chelation to 
abolish adhesion via receptors described to date is essential. 
 
7.1.4. Formation of pseudopodia and F-actin 
 
With activation of neutrophils, globular G-actin is rapidly converted to 
filamentous F-actin, but the F-actin content then decreases partway towards its initial 
level [45]. At the same time, pseudopodia form. Morphological examination of fixed 
neutrophils can be used to assess the proportion which are activated (i.e., the 
percentage with distorted instead of smooth spherical shapes). Cell shape can be 
quantitated using: 1) isolated neutrophils [67]; 2) stained blood films [61]; 3) whole 
blood fixed relatively mildly, followed by lysis of red cells [63]. The percentage of 
morphologically active cells has been found to correlate strongly with impaired 
filterability for purified cell suspensions [67]. F-actin content can be measured by 
quantifying the binding of fluorescent phalloidin to F-actin [45]. However, while actin 
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polymers clearly contribute to changes in neutrophil rigidity, there may not be an 
exact correlation between F-actin level and overall cell deformability [74].  
 
7.2. Measurement of leukocyte adhesion 
 
7.2.1. Surface attachment 
 
Adhesion of isolated leukocytes can be tested by settling them onto surfaces 
coated with receptor proteins or with cultured endothelial cells [19]. The incubation 
time prior to washing off non-adherent cells need only be of the order of minutes. 
Quantification of adhesion can be done by direct microscopic counting of the cells or 
by using leukocytes loaded with dyes and the dye quantified; use of radio-labeling is 
no longer popular, and fluorescent dyes are more commonly used.  
 
Monitoring the adhesive behavior of neutrophils may be based on their 
capability to attach to selectins, adhesion molecules of the immunoglobulin 
superfamily, to purified proteins from plasma (e.g., albumin or fibrinogen) or to 
proteins found in the extracellular matrix such as collagen, laminin, fibronectin. 
Concentrations of these agents that are used to coat a surface are typically of the 
order of microgram per ml. Binding to selectins should be efficient for unstimulated 
neutrophils, while the other receptors all bind specific integrins which generally 
require conformational activation to bind efficiently. The limiting factors are thus 
expression of selectin ligands which tend to decrease on activation and neutrophil 
activation that increases integrin binding. Cultured endothelial cells which have been 
stimulated with cytokines such as tumor necrosis factor-α or interleukin-1β present 
selectins and integrin-ligands as well as activating agents. 
 
To distinguish clearly between contributions from selectin-mediated and 
integrin-mediated adhesion when both are possible, or to test the influence of fluid 
forces on adhesion, flow-based assays are required. In flow, selectins support rolling 
adhesion, while integrins support immobilization. Various forms of flow chambers 
have been described for flow assays, and flow rates are chosen to mimic conditions 
in post-capillary venules where neutrophil recruitment occurs in vivo. Whole blood 
has rarely been used in adhesion assays. In flow-based assays with blood, adhesion 
depends on hematocrit and red cell aggregation [2]. It may therefore be difficult to 
separate the effects of the hemorheological variables from the adhesive properties of 
the leukocytes themselves. 
 
Because of difficulties in obtaining blood borne leukocytes or isolation 
problems, and difficulties in obtaining endothelial cells for adhesion studies, cell lines 
may be used to investigate the roles of specific receptors. Erythroid K562 or leukemic 
HL60 cell lines can be conditioned to express adhesion molecules and can be used 
to explore the molecules involved in cell-cell adhesion. Chemically or genetically 
modified cell lines can be used in flow systems to further investigate the molecular 
alterations responsible for increased adhesion to endothelial cells or to coated 
surfaces [92]. For adhesion studies of specific receptors on endothelium, genetically 
modified cells lines, expressing only the receptor of interest, can be used as a 
substrate for leukocyte adhesion.  
 
7.2.2. Leukocyte aggregation 
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A technically straight-forward measurement is to quantitate cell-cell 
aggregation, usually neutrophil-neutrophil but neutrophil-platelet aggregation can 
also be studied. Neutrophil aggregation can be measured in whole blood or in 
isolated preparations by cell counting techniques [31, 53].  Immunofluorescence 
and flow cytometry can be used with whole blood to detect aggregates which bear 
fluorescently-labeled antigens characteristic of neutrophils and platelets [80]. 
Leukocyte-platelet aggregation has been found to be elevated in several clinical 
conditions including, for instance, post-cardio-pulmonary bypass [79]. 
 
7.2.3. Expression of surface adhesion receptors 
 
Since adhesion of neutrophils depends on surface-presented integrins, L-
selectin or selectin ligands, measurement of the expression of these receptors using 
fluorescently-labeled antibodies and flow cytometry may be a surrogate for an 
adhesion assay. Measurement of the level of surface expression of integrins CD11b 
and CD18 can be used to monitor adhesive potential [14]. After cell activation, 
CD11b rises more than CD18. In addition, the method can be applied to whole blood 
for clinical studies, where expression may be lower than on isolated cells because of 
the lack of preparative trauma [72]. However, it may be noted that the conformation 
of integrins is important in defining adhesive potential. Antibodies specifically binding 
to epitopes exposed on activated integrins are available [32], and may be used to 
quantify active receptors. 
Since it is known that L-selectin is shed from neutrophils upon activation, 
reduction in expression should also indicate activation [73]. In fact, plasma contains 
a high level of the presumably-shed molecule, and an alternative approach to 
measure CD11b on neutrophils has been to detect the level of soluble L-selectin in 
plasma. Increasing concentrations of L-selectin due to shedding have been shown to 
correlate with positive prognosis in septic shock [34]. 
 
7.3. Precautions and interpretation of data 
 
The major problem common to assessment of all aspects of neutrophil 
function is the inherent reactivity of the cells, and thus their behavior may shift 
significantly due to experimental conditions. Isolation of cells itself represents a 
stimulus. For example, basal expression of CD11b is increased in isolated 
neutrophils compared to cells in whole blood and the response to subsequent 
activation is decreased [14]. In one sense, sensitization during preparation may be 
useful. In clinical conditions, neutrophils may be primed rather than fully activated, 
and then the isolation procedure itself may act as a stimulus to which a higher 
response is seen in patients compared to controls. Given the high degree of 
activation and increase in flow resistance of isolated cells seen in some clinical 
studies [67], and that these levels would seem unlikely to be compatible with 
continued circulation in vivo, it seems that isolation contributes to abnormalities 
detected in vitro. 
 
Methods utilizing whole blood or minimal manipulation are highly desirable if 
one wishes to characterize the in vivo state. Whole blood can be used to measure 
leukocyte deformability in some filtration devices [30], for analysis of expression of 
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adhesion receptors [14], measurement of cell-cell aggregation [80], and cell 
morphology with pseudopod formation [61]. Even if an activating stimulus may be 
present in vivo, the cells may be responding over time after withdrawal of whole 
blood. In detection of CD11b levels of expression, fixation itself and the period for 
which cells are held fixed before labeling with fluorescent antibody can markedly 
influence the intensity of fluorescence. The method of cell handling must therefore be 
standardized in any series of tests or, for instance, when following changes during a 
procedure such as cardiopulmonary bypass. 
 
There is a close relationship between neutrophil mechanics, adhesion and 
activation. It is thus recommended that the state of cell activation be documented in 
clinical studies since this assists interpretation of rheological studies. As noted above, 
activation may be assessed from morphology, expression of adhesion molecules and 
content of F-actin. Other possibilities are to measure the oxidative potential or status 
of neutrophils using oxidant sensitive dyes or markers of degranulation such as 
elastase level in plasma. However, there have been relatively few attempts to 
critically evaluate adhesion methods for clinical studies. Most studies have used 
increased expression of integrins or loss of L-selectin as indicators of activation and 
change in adhesive potential. Aggregation of neutrophils or neutrophils with platelets 
may be easier to standardize, and are better adapted to the use of whole blood than 
are studies of adhesion to surfaces. While in principle flow-based studies of adhesion 
yield more detailed and more clearly interpretable results, they require specialized 
expertise and are seldom used for clinical studies. 
 
 
8. Study design and statistical considerations 
 
8.1. Reference population and matched controls for clinical studies 
 
Reference ranges for hemorheological parameters are necessary when used 
for clinical purposes. These reference ranges should be obtained for each instrument 
and each parameter using samples from a healthy reference population [50]; an 
approach for determining  clinical chemistry reference ranges may be relevant for 
hemorheological parameters [4]. Hemorheological parameters are known to be 
influenced by the following factors: age, sex, ethnicity, obesity, fitness level, smoking, 
medication, menstrual cycle [52]. Therefore, these factors should be standardized 
as best as possible. Those diseases known to affect hemorheological parameters 
[85] should be excluded.  
 
Based on these considerations, samples should be obtained from 20-30 year 
old subjects with no obvious health problems and with normal hematological indices. 
They should not smoke or be routinely taking any medication. Separate groups 
should be formed for male and female subjects. Ethnicity should be standardized if 
possible or at least mentioned. Fitness level should be taken into account and 
sedentary subjects should be preferred. Control groups used in clinical studies 
should be age and sex matched.  
 
All procedures related to the determination of control or reference 
hemorheological parameters should exactly match the procedures used with patient 
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groups. These include the details of sampling such as tourniquet application, 
anatomical sampling site and procedures, anticoagulant, time delay between 
sampling and the actual measurement and sample preparation procedures. 
 
8.2. Instrument specifications – Precision, Specificity, Sensitivity 
 
The precision of the method or instrument used in a given study should be 
tested and reported. This is especially important for custom-built devices and newly 
developed methods. The precision can be assessed as the coefficient of variation 
(CV) of 10 repeated measurements on the same sample from a healthy control 
subject [87]. This can be expressed in two ways: 1) CV of replicate measurements 
of a single sample using the same instrument (i.e., instrument precision, intra-assay 
variability); 2) CV of 10 measurements on separately prepared samples using the 
same aliquot of blood (i.e., procedural variability). Obviously, procedural variability 
includes the variation introduced by the sample preparation procedures (e.g., 
hematocrit adjustment).  
 
Biological variability of a given hemorheological parameter should be 
considered as an important determinant of the value of that method or parameter in 
detecting a “meaningful” difference between two groups (e.g., control and patient 
groups). Biological variability contributes to the “standardized difference” which can 
be calculated by dividing the difference between the mean values of the groups by 
the standard deviation of either group (if the variances of the two groups are 
homogenous).  Alternatively, a “pooled standard deviation” can be used as the 
denominator which can be calculated as the square root of the sum of the squared 
standard deviations of the two groups [25]. The standardized difference is a 
measure of the power of a method or parameter to detect a difference in 
hemorheological parameters between two groups within a given study design[87]. 
Alternatively, the standardized difference for a hemorheological parameter can be 
used to calculate the size of the groups to be able to detect a given difference [87]. 
While comparing the two hemorheological parameters in terms of their standardized 
differences, a higher value indicates a higher probability to detect a given difference 
between the two groups. 
 
The value of hemorheological parameters in clinical studies can be judged by their 
diagnostic sensitivity and specificity [37, 39, 40, 85]. Sensitivity, as a percent, is 
defined as 100 times the ratio of (true positive findings) / (true positive findings + 
false negative findings) in a patient group, and is the precision with which a sick 
person can be identified. Specificity, as a percentage, is defined as 100 times the 
ratio of (true negative findings) / (true negative findings + false positive findings) in a 
control or reference group, and is the precision with which healthy subjects can be 
excluded. Obviously, the merit of any hemorheological parameter will depend upon it 
having both high sensitivity and specificity.    
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